-
Sanofi and GSK partner to develop Covid-19 vaccine
pharmaceutical-technology
April 15, 2020
Sanofi and GlaxoSmithKline (GSK) have signed a letter of intent for a partnership focused on developing an adjuvanted vaccine for Covid-19.
-
Jenner Institute, MilliporeSigma to Scale Up Covid-19 Vax Production
contractpharma
April 15, 2020
Develops a rapid, scalable platform following good manufacturing practices and using disposable technologies.
-
Immunomic partners EpiVax and PharmaJet on Covid-19 vaccine
pharmaceutical-technology
April 14, 2020
Biotechnology firm Immunomic Therapeutics has partnered with EpiVax and PharmaJet to develop a vaccine candidate against Covid-19 infection.
-
iBio Expands COVID-19 Vaccine Collaboration
contractpharma
April 14, 2020
Now includes the Infectious Disease Research Institute to help lead pre-clinical development and clinical trial oversight.
-
China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data
Fiercepharma
April 13, 2020
In the global race to develop an effective vaccine to protect people against the novel coronavirus, China’s CanSino Bio has leapt ahead.
-
Pfizer identifies lead coronavirus drug candidate
pharmaceutical-technology
April 13, 2020
Pfizer has announced progress in its research programme to develop antivirals and vaccine for the Covid-19 coronavirus infection.
-
Vaccines Industry Witnesses Essential Demand in Efforts to Safeguard the Population Against COVID-19
prnewswire
April 10, 2020
ResearchAndMarkets.com identifies Unified Communications as one of the key industries seeing increased demand due to the Coronavirus pandemic.
-
Australia’s UQ Covid-19 vaccine candidate advances to preclinical tests
pharmaceutical-technology
April 10, 2020
The University of Queensland (UQ) in Australia has progressed its Covid-19 vaccine candidate into preclinical testing stage.
-
Indian Immunologicals, Griffith University to develop Covid-19 vaccine
pharmaceutical-technology
April 09, 2020
Vaccine manufacturer Indian Immunologicals and Griffith University in Australia have partnered to develop a potential vaccine candidate against Covid-19.
-
Oxford Biomedica joins consortium for coronavirus vaccine
pharmaceutical-technology
April 09, 2020
UK-based gene and cell therapy group Oxford Biomedica has become part of a consortium focussed on the development, scale-up and production of a Covid-19 coronavirus vaccine candidate.